Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.14
Bid: 40.10
Ask: 40.14
Change: 0.14 (0.35%)
Spread: 0.04 (0.10%)
Open: 40.16
High: 40.20
Low: 40.08
Prev. Close: 40.00
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Financial Officer

4 Aug 2017 07:00

RNS Number : 0712N
Assura PLC
04 August 2017
 

 

4 August 2017

 

Assura plc

 

Appointment of Chief Financial Officer

 

Assura plc ("Assura" or the "Company"), the leading investor and developer of primary care properties, is pleased to announce the appointment of Jayne Cottam to the Board as Chief Financial Officer ("CFO"). Jayne is expected to join the Company before the end of October 2017. Jonathan Murphy has continued to fulfil the role of CFO since his appointment earlier this year as Chief Executive Officer ("CEO") and will do so until Jayne joins Assura.

Jayne, a CIMA qualified accountant, joins Assura from one of the UK's largest private national housing developers. She is currently the Finance Director for Operations, heading up the operational finance team across the group and providing financial and strategic support as a member of the board for each of the three operating regions. Jayne was previously Director of Finance for the Continental Europe Division of European Metal Recycling Limited, one of the worlds' largest metal recyclers, and before that held a number of other senior finance positions.

Jonathan Murphy, CEO of Assura, commented:

"I am delighted that Jayne Cottam will be joining Assura as Chief Financial Officer. Jayne brings a wealth of relevant experience and her financial expertise will prove extremely valuable as we continue to deliver shareholder value and pursue our strategy of investing to support the UK's primary healthcare infrastructure."

Commenting on her appointment, Jayne Cottam said:

"Assura has built a strong business with many opportunities for further growth in a still-developing sector. I am very excited to be joining the Company and look forward to working with Jonathan and the team in helping to support the NHS in providing them with the buildings they need today for the NHS of the future."

There are no further disclosures required pursuant to paragraph 9.6.13 of the Listing Rules.

 

- Ends -

 

 

For more information, please contact:

 

Assura plc

 

Tel: 01925 420660

Jonathan Murphy

 

Orla Ball

 

 

Finsbury

 

Tel: 0207 251 3801

Gordon Simpson

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2017, Assura's property portfolio was valued at £1,345 million.

 

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGURPRUPMGCW
Date   Source Headline
16th Apr 202010:50 amRNSDirector/PDMR Shareholding
14th Apr 202012:38 pmRNSReplacement Scrip Dividend Declaration
14th Apr 20207:00 amRNSNotification of Major Interests in Shares
14th Apr 20207:00 amRNSNotification of Major Interests in Shares
9th Apr 20207:00 amRNSScrip Dividend Declaration
7th Apr 20207:00 amRNSResults of Placing
6th Apr 20204:42 pmRNSProposed equity placing of new ordinary shares
2nd Apr 20207:00 amRNSTrading update
20th Mar 20207:00 amRNSScrip Calculation Price
13th Mar 20204:46 pmRNSNotification of Major Interests in Shares
5th Mar 20207:00 amRNSNotice of Dividend
24th Feb 20203:40 pmRNSNotification of Major Interests in Shares
20th Feb 20209:13 amRNSNotification of Major Interests in Shares
17th Jan 202011:27 amRNSDirector/PDMR Shareholding
13th Jan 20207:00 amRNSScrip dividend declaration
13th Jan 20207:00 amRNSTrading update
6th Jan 202012:11 pmRNSNotification of Major Interests in Shares
19th Dec 20191:43 pmRNSDirector/PDMR Shareholding
19th Dec 201910:15 amRNSScrip Calculation Price
10th Dec 201911:01 amRNSNotification of Major Interests in Shares
5th Dec 20199:02 amRNSNotice of Dividend
12th Nov 20197:00 amRNSInterim Results 2019
1st Nov 20199:48 amRNSDirector Declaration
18th Oct 20194:31 pmRNSNotification of Major Interests in Shares
17th Oct 20199:46 amRNSDirector/PDMR Shareholding
14th Oct 20197:00 amRNSScrip Dividend Declaration
3rd Oct 20197:00 amRNSTrading Update
19th Sep 201910:19 amRNSScrip Calculation Price
9th Sep 201911:25 amRNSPDMR Notification
5th Sep 20197:00 amRNSNotice of Dividend
21st Aug 20194:27 pmRNSNotification of Major Interests in Shares
13th Aug 20194:10 pmRNSExercise of Nil Cost Options under PSP
9th Aug 20192:40 pmRNSAdditional Listing
8th Aug 20197:00 amRNSNote issuance
17th Jul 20193:07 pmRNSPersons Discharging Managerial Responsibilities
15th Jul 20197:00 amRNSScrip Dividend Declaration
3rd Jul 20194:03 pmRNSPDMR Notification
2nd Jul 20192:41 pmRNSResult of AGM
2nd Jul 20197:00 amRNSTrading Update
20th Jun 201911:45 amRNSScrip Calculation Price
10th Jun 20193:46 pmRNSNotification of Major Interests in Shares
6th Jun 20197:00 amRNSNotice of Dividend
5th Jun 20199:00 amRNSNotification of Major Interests in Shares
4th Jun 20193:10 pmRNSPDMR Notification
30th May 20197:00 amRNSAnnual Report and Notice of AGM
30th May 20197:00 amRNSAppointment of Non-Executive Director
21st May 20197:00 amRNSAssura Full Year Results
20th May 201910:41 amRNSDirectorate Change
17th Apr 20192:35 pmRNSPersons Discharging Managerial Responsibilities
15th Apr 20197:00 amRNSScrip Dividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.